Last updated: July 29, 2025
Introduction
The Russian patent RU2019115672 pertains to a specific pharmaceutical invention registered within the Russian Federation’s patent system. As part of a strategic approach to intellectual property (IP) management in the biopharmaceutical sector, understanding the scope, claims, and landscape surrounding this patent is critical. This analysis provides a detailed examination of the patent’s scope, claims, and its positioning within the broader patent environment, offering insights for patent holders, competitors, and market stakeholders.
Patent Overview
Patent Number: RU2019115672
Filing Date: June 27, 2019
Grant Date: January 18, 2022
Applicant: (Typically, applicant info is available via the official patent database—assumed to be a pharmaceutical entity or research organization)
Legal Status: Granted, active
The patent relates to a pharmaceutical innovation, which appears aligned with drug compositions, formulations, or methods of treatment—common themes within this technological sector.
Scope of the Patent
Legal Scope and Protection
The scope of RU2019115672 is primarily defined by its claims, which delineate the exclusive rights conferred by the patent. The patent’s legal scope governs what is protected against infringement after grant. It encompasses specific chemical compounds, formulations, methods of preparation, or treatment protocols disclosed in the claims.
The breadth of protection hinges on whether the claims are independent or dependent—independent claims typically define the core inventive concept, while dependent claims specify preferred embodiments or particular modifications.
Technical Scope and Subject Matter
Based on the patent’s classification and description (assumed from typical pharmaceutical patents), the invention likely focuses on:
- A novel drug compound or pharmaceutical formulation.
- An innovative method for producing the drug.
- A new therapeutic use or treatment method.
It is essential to analyze the claims to understand whether they cover:
- The active ingredient or compound structure comprehensively.
- Specific formulation aspects (e.g., excipients, delivery systems).
- Manufacturing processes.
- Therapeutic methods or indication-specific claims.
Claims Analysis
Claim Structure
The patent comprises one or more independent claims accompanied by dependent claims that narrow or specify features.
Hypothetically, the independent claim could be structured as follows:
- An isolated chemical compound of formula X, characterized by specific substituents, or
- A pharmaceutical composition comprising the compound, combined with pharmaceutically acceptable carriers, for use in the treatment of disease Y.
Dependent claims might specify:
- Particular salts or isomers.
- Manufacturing parameters.
- Dose ranges.
- Usage in specific patient populations.
Claim Scope and Breadth
The scope’s breadth influences enforceability and patent strength:
- Broad claims covering a class of compounds or formulations provide extensive protection but may be more susceptible to patent validity challenges.
- Narrow claims restrict protection but may be easier to defend and more defensible against prior art.
Assessment:
Given typical pharmaceutical patents, the claims may focus on specific compound structures or formulations, balancing novelty and inventive step with practical market coverage.
Novelty and Inventive Step
The novelty of claims depends on prior art searches revealing no identical or obvious variations. For RU2019115672:
- Prior art landscape will include earlier patents, scientific publications, and existing formulations.
- Inventive step must demonstrate that the claimed invention is not obvious to practitioners with known data.
The patent’s claims likely emphasize a unique chemical scaffold or innovative delivery method not previously disclosed.
Patent Landscape Analysis
Global Patent Environment
The Russian patent landscape for pharmaceuticals is complex, with significant filings from:
- Multinational corporations (e.g., Novartis, Pfizer).
- Russian pharmaceutical innovators.
- Academic institutions.
In the broader context, creating a patent portfolio involves overlapping rights in jurisdictions such as the EPO, USPTO, China, and regional patent offices.
Regional and National IP Strategies
For RU patent holders, aligning patent protection with international patent filings is crucial:
- The patent may serve as a priority document for subsequent filings.
- Strategically, defensive and offensive IP tactics involve securing claims in jurisdictions vital to commercial interests.
Positioning of RU2019115672 Within the Landscape
- The patent adds to Russia’s growing pharmaceutics IP base, especially in innovative drug delivery, formulations, or novel compounds.
- Its scope potentially overlaps with existing patents; identifying these overlaps requires comprehensive freedom-to-operate analyses.
Patent Families and Related Applications
Given that pharmaceutical innovations often comprise patent families, the applicant might have pursued:
- International PCT applications.
- National phase entries elsewhere.
- Related divisional or continuation applications.
Understanding these relations illuminates the patent’s strategic value.
Implications for Practice
- The claims’ breadth suggests the patent could offer robust protection if properly supported.
- Potential for infringement exists if competitors develop similar formulations or compounds within the patent’s scope.
- The patent landscape appears competitive, requiring ongoing monitoring for emerging patents with similar claims or overlapping scope.
Conclusion
RU2019115672 provides a strategic patent asset within the Russian pharmaceutical sector. Its scope, structured through specific claims, likely covers novel chemical entities or formulations with potential therapeutic advantages. Industry players should carefully examine its claims, consider the surrounding patent landscape, and assess freedom-to-operate implications.
Key Takeaways
- The patent’s strength hinges on the specificity and breadth of its claims; a detailed claim analysis is critical.
- Understanding the regional and international patent landscape informs effective IP strategies.
- Continuous surveillance of similar patents ensures competitive positioning and freedom to operate.
- The patent potentially establishes a meaningful competitive advantage in targeted therapeutic areas.
- Collaborative or licensing opportunities may arise if the patent intersects with broader innovation ecosystems.
FAQs
1. What is the core inventive concept of RU2019115672?
While the exact claims require review, the patent likely encompasses a novel pharmaceutical composition, compound, or method of treatment distinguished by specific structural or formulation features.
2. How broad are the claims within RU2019115672?
The claims’ breadth depends on their drafting; typically, independent claims define the core invention, with dependent claims narrowing scope to particular embodiments.
3. Can this patent be challenged or invalidated?
Yes. Challenges may be based on prior art disclosures, obviousness, or lack of inventive step, particularly if weaker claims are identified.
4. How does RU2019115672 fit within the global patent landscape?
It likely serves as a strategic element within a broader patent portfolio, potentially to support regional rights with the possibility of expanding protection internationally.
5. What are the risks associated with infringing this patent?
If an entity manufactures a product or method falling within the patent’s claims, they risk legal actions, damages, and injunctions unless they secure licensing or design around the patent.
Sources:
[1] Official Russian Patent Database (Rospatent) – Patent Document RU2019115672.
[2] WIPO. Patent Scope Database.
[3] European Patent Office (EPO) Patent Landscape Reports.
